Healthcare Decliners: InspireMD Inc (NYSEMKT:NSPR), Agenus Inc (NASDAQ:AGEN), InfuSystem Holdings Inc (NYSEMKT:INFU), Auxilium Pharmaceuticals (NASDAQ:AUXL), Agile Therapeutics Inc (NASDAQ:AGRX)

On June 23, 2014, InspireMD Inc (NYSEMKT:NSPR), a leader in embolic protection systems (EPS), announced that it received European regulatory approval to resume the manufacturing of its MGuard Prime EPS stent with a modified stent securement process . The Company also received approval to modify and re-deploy existing MGuard Prime EPS stents that have been returned by clinical and commercial sites worldwide. InspireMD Inc (NYSEMKT:NSPR), weekly performance is -4.53%. On last trading day company shares ended up $2.95. Analysts mean target price for the company is $5.17. InspireMD Inc (NYSEMKT:NSPR), distance from 50-day simple moving average (SMA50) is 14.89%.

On June 16, 2014, Agenus Inc (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs) heat shock protein vaccines and adjuvants announced that it has been selected for inclusion in the broad-market Russell 3000Index and Russell Global Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27 2014 according to a preliminary list of additions on www.russell.com/indexes. Agenus Inc (NASDAQ:AGEN), fell % in last t5.29rading session and ended the day on $3.22. AGEN, Gross Margin is 88.90% and its return on assets is -67.10%. Agenus Inc (NASDAQ:AGEN), quarterly performance is 1.58%.

InfuSystem Holdings Inc (NYSEMKT:INFU), shares moved down 5.36% in last trading session and was closed at $2.65, while trading in range of $2.64 – 2.79. The Southern Company (NYSE:SO), year to date (YTD) performance is 23.83%.

Equities researchers at Aegis started coverage on shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), in a research report issued on Thursday. The firm set a “buy” rating and a $37.00 price target on the stock. Aegis’ target price would indicate a potential upside of 74.28% from the company’s current price. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), ended the last trading day at $20.06. Company weekly volatility is calculated as 4.74% and price to cash ratio as 13.16. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), showed a negative weekly performance of 8.15%.

Agile Therapeutics Inc (NASDAQ:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced it has been added to the Russell Microcap Index. The company joined the index at the close of the market on Friday, June 27, when Russell Investments reconstituted its U.S. and global equity indexes. Agile Therapeutics Inc (NASDAQ:AGRX), weekly performance is -15.59%. On last trading day company shares ended up $8.72. Analysts mean target price for the company is $16.25. Agile Therapeutics Inc (NASDAQ:AGRX), distance from 50-day simple moving average (SMA50) is 22.60%.